A Phase I/II Study of a 72-h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma

Purpose. The study was performed to assess the antitumour activity and toxicity of a 72-h continuous infusion of single-agent etoposide as second-line treatment for patients with locally advanced or metastatic soft tissue sarcoma (STS), following reports of substantial activity using this schedule o...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawley, Charles R., Judson, Ian R., Verrill, Mark, Hill, Catherine, Raynaud, Florence I.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395367/
https://www.ncbi.nlm.nih.gov/pubmed/18521217
http://dx.doi.org/10.1080/13577149778236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395367/
https://www.ncbi.nlm.nih.gov/pubmed/18521217
http://dx.doi.org/10.1080/13577149778236

Ejemplares similares